Bright Minds Biosciences Inc. (DRUG)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20260 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Bright Minds Biosciences Inc.’s names, not what it holds today.
4 published
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Sep 25, 2025 | 2025/0296934 | AZEPINOINDOLES AND METHODS OF PREPARATION THEREOF | Organic fine chemistry | BRIGHT MINDS BIOSCIENCES INC. |
| Mar 6, 2025 | 2025/0074871 | PHENETHYLAMINES AND METHODS OF PREPARATION THEREOF | Organic fine chemistry | BRIGHT MINDS BIOSCIENCES INC. |
| Feb 20, 2025 | 2025/0059217 | HETEROCYCLIC COMPOUNDS AND METHODS OF PREPARATION THEREOF | Organic fine chemistry | BRIGHT MINDS BIOSCIENCES INC. |
| May 4, 2023 | 2023/0140635 | 3-(2-(Aminoethyl)-Indol-4-ol Derivatives, Methods of Preparation Thereof, and the Use as 5-HT2 Receptor Modulators | Pharmaceuticals | BRIGHT MINDS BIOSCIENCES INC. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.